Last month, IceCure Medical’s tumor-freezing technology won FDA approval for treating early-stage breast cancer. Now, the Israel-based medtech is touting a new study showing its procedure combined ...
Icecure Medical ( ($ICCM) ) has shared an update. On November 3, 2025, IceCure Medical announced the successful results of an independent study ...
A Phase 2 trial testing experimental therapy CAL101 in people with IPF is recruiting participants. CAL101 has been granted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback